Considering the heterogeneity of RKIP expression in cancer types, future studies should deploy similar procedures, a plasmid that triggers overexpression of the RKIP gene, in distinct cancer types to evaluate the effects on tumor invasion and metastasis. Here, PEBP1 is linked to neoplasm.